Prognostic importance of survivin in breast cancer

British Journal of Cancer

Volumn 88, Issue 7, 2003, Pages 1077-1083

  Kennedy, S M ^a,b,e   O'Driscoll, L ^c   Purcell, R ^a,c   Fitz Simons, N ^a   McDermott, E W ^b,d   Hill, A D ^b,d   O'Higgins, N J ^b,d   Parkinson, M ^c   Linehan, R ^c   Clynes, M ^c  

^a Royal Eye and Ear Hospital ^*  (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c DUBLIN CITY UNIVERSITY   (Ireland)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

^e ROYAL VICTORIA EYE AND EAR HOSPITAL   (Ireland)

Author keywords

Apoptosis; Breast cancer; IAPs; Immunohistochemistry; Prognostic indicator; Survivin

Indexed keywords

ESTROGEN RECEPTOR; POLYCLONAL ANTIBODY; SURVIVIN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; CYTOCHEMISTRY; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; RETROSPECTIVE STUDIES;

EID: 0038030728     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600776     Document Type: Article

References (38)

1. Adida C, Haioun C, Galliard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ (2000a) Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 96: 1921-1925
2. Adida C, Recher C, Raffoux E, Daniel MT, Taksin AL, Rousselot P, Sigaux F, Degos L, Altieri DC, Dombret H (2000b) Expression and prognostic significance of survivin in de novo acute myeloid leukaemia. Br J Haematol 111: 196-203
3. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921
4. Ambrosini G, Adida C, Sirugo G, Altieri DC (1998) Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting. J Biol Chem 273: 11177-11182
5. Deveraux QL, Reed JC (1999) IAP family proteins - suppressors of apoptosis. Genes Dev 13: 239-252
6. Duenas-Gonzalez A, Abad-Hernandez MM, Cruz-Hernandez JJ, Gonzalez-Sarmiento R (1997) Analysis of bcl-2 in sporadic breast carcinoma. Cancer 80: 2100-2108
7. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
8. Fogt F, Poremba C, Shibao K, Itoh H, Kohno K, Zimmerman RL, Gortz HG, Dockhorn-Dworniczak B, Urbanski SJ, Alsaigh N, Heinz D, Noffsinger AE, Shroyer KR (2001) Expression of survivin, YB-1, and KI-67 in sporadic adenomas and dysplasia-associated lesions or masses in ulcerative colitis. Appl Immunohistochem Mol Morphol 9: 143-149
9. Fortugno P, Wall NR, Giodini A, O'Connor DS, Plescia J, Padgett KM, Tognin S, Marchisio PC, Altieri DC (2002) Survivin exists in immunochemicaily distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 115: 575-585
10. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR (2001) Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32: 119-125
11. Islam A, Kageyama H, Takada N, Kawamoto T, Takayasu H, Isogai E, Ohira M, Hashizume K, Kobayashi H, Kaneko Y, Nakagawara A (2000a) High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma. Oncogene 19: 617-623
12. Islam A, Kageyama H, Hashizume, Kaneko Y, Nakagawara A (2000b) Role of survivin, whose gene is mapped to 17q25, in human neuroblastoma and identification of a novel dominant-negative isoform, survivin-beta/2B. Med Pediatr Oncol 35: 550-553
13. Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, Takase K, Moriyama M, Kawano H, Hayashida M, Nakano T, Suzuki A (2000) Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology 31: 1080-1085
14. Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T, Tanigawa N (1998) Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res 58: 5071-5074
15. Konno R, Yamakawa H, Utsunomiya H, Ito K, Sato S, Yajima A (2000) Expression of survivin and Bcl-2 in the normal human endometrium. Mol Hum Reprod 6: 529-534
16. Krieg A, Mahotka C, Krieg T, Grabsch H, Muller W, Takeno S, Suschek CV, Heydthausen M, Gabbert HE, Gerharz CD (2002) Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression. Br J Cancer 86: 737-743
17. LaCasse EC, Baird S, Korneluk RG, MacKenzie AE (1998) The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene 17: 3247-3259
18. Leek RD, Kaklamanis L, Pezzeila F, Gatter KC, Harris AL (1994) bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69: 135-139
19. Li F, Ackermann EJ, Bennett CF, Rothermel AL, Plescia J, Tognin S, Villa A, Marchisio PC, Altieri DC (1999) Pleiotropic cell-division defects and apoptosis induced by interference with survivin function. Nat Cell Biol 1: 461-466
20. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584
21. Mahotka C, Wenzel M, Springer E, Gabbert HE, Gerharz CD (1999) Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res 59: 6097-6102
22. Monzo M, Roseil R, Felip E, Astudillo J, Sanchez JJ, Maestre J, Martin C, Font A, Barnadas A, Abad A (1999) A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 17: 2100-2104
23. Nakagawara A (1998) Molecular basis of spontaneous regression of neuroblastoma: role of neurotrophic signals and genetic abnormalities. Hum Cell 11: 115-124
24. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC, Altieri DC (2000) Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97: 13103-13107
25. Okada E, Mural Y, Matsui K, Isizawa S, Cheng C, Masuda M, Takano Y (2001) Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett 163: 109-116
26. Page DL, Anderson T (1987) Diagnostic Histopathology. London, Melbourne and New York: Churchill Livingstone.
27. Reed JC (2001) The Survivin saga goes in vivo. J Clin Invest 108: 965-969
28. Sarela AI, Macadam RC, Farmery SM, Markham AF, Guillou PJ (2000) Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 46: 645-650
29. Satoh K, Kaneko K, Hirota M, Masamune A, Satoh A, Shimosegawa T (2001) Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors. Cancer 92: 271-278
30. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, Chung CW, Jung YK, Oh BH (2001) An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40: 1117-1123
31. Sobin L (1997) TNM Classification of Malignant Tumours. New York: John Wiley and Sons
32. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC (1999) Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 341: 452-453
33. Takamizawa S, Scott D, Wen J, Grundy P, Bishop W, Kimura K, Sandler A (2001) The survivin: fas ratio in pediatric renal tumors. J Pediatr Surg 36: 37-42
34. Takano Y, Kato Y, Masuda M, Ohshima Y, Okayasu I (1999) Cyclin D2, but not cyciln D1, overexpression closely correlates with gastric cancer progression and prognosis. J Pathol 189: 194-200
35. Takano Y, Kato Y, van Diest PJ, Masuda M, Mitomi H, Okayasu I (2000) Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156: 585-594
36. Tamm I, Wang Y, Sausville E, Scudiero DA, Vigna N, Oltersdorf T, Reed JC (1998) IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. Cancer Res 58: 5315-5320
37. Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M, Tanigawa N (2000) Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res 6: 127-134
38. Xing N, Qian J, Bostwick D, Bergstralh E, Young CY (2001) Neuroendocrine cells in human prostate over-express the anti-apoptosis protein survivin. Prostate 48: 7-15